Results
13
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
13 companies
AddLife
Market Cap: SEK 22.5b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 184.40
7D
3.6%
1Y
61.2%
Bonesupport Holding
Market Cap: SEK 16.7b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 254.20
7D
-3.6%
1Y
-0.08%
BioGaia
Market Cap: SEK 10.1b
A healthcare company, provides probiotic products worldwide.
BIOG B
SEK 99.05
7D
-2.5%
1Y
-22.5%
Swedencare
Market Cap: SEK 6.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 40.00
7D
5.5%
1Y
-32.4%
Devyser Diagnostics
Market Cap: SEK 1.7b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 105.20
7D
5.2%
1Y
0.7%
Enzymatica
Market Cap: SEK 728.2m
A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.
ENZY
SEK 3.00
7D
-2.6%
1Y
-5.1%
Orexo
Market Cap: SEK 501.0m
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 14.52
7D
-6.2%
1Y
-27.4%
Promimic
Market Cap: SEK 358.0m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 18.95
7D
6.8%
1Y
-41.3%
Mendus
Market Cap: SEK 275.0m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.28
7D
2.7%
1Y
-47.9%
SenzaGen
Market Cap: SEK 154.0m
Provides non-animal tests for assessing a substance’s allergenicity.
SENZA
SEK 5.22
7D
0.4%
1Y
-39.7%
Biovica International
Market Cap: SEK 74.7m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.76
7D
0.3%
1Y
-68.2%
OncoZenge
Market Cap: SEK 62.8m
A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 5.36
7D
4.1%
1Y
54.9%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%